Atom Investors LP - POINT BIOPHARMA GLOBAL INC ownership

POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 56 filers reported holding POINT BIOPHARMA GLOBAL INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Atom Investors LP ownership history of POINT BIOPHARMA GLOBAL INC
ValueSharesWeighting
Q1 2023$231,339
-56.5%
31,821
-56.4%
0.13%
-52.6%
Q4 2022$532,031
+9.0%
72,981
+15.5%
0.27%
+54.7%
Q3 2022$488,000
+559.5%
63,169
+485.3%
0.17%
+437.5%
Q2 2022$74,000
-84.6%
10,793
-82.0%
0.03%
-85.7%
Q1 2022$479,000
+399.0%
60,103
+251.6%
0.22%
+1300.0%
Q4 2021$96,00017,0960.02%
Other shareholders
POINT BIOPHARMA GLOBAL INC shareholders Q4 2021
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 2,312,523$18,431,0004.36%
GREAT POINT PARTNERS LLC 2,060,000$16,418,0003.97%
RA Capital Management 9,003,018$71,754,0001.57%
JOHNSON & JOHNSON 1,000,000$7,970,0001.51%
BVF INC/IL 3,367,826$26,842,0001.07%
Boxer Capital, LLC 2,500,000$19,925,0001.02%
Sio Capital Management, LLC 377,684$3,010,0001.00%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,014,408$24,025,0000.73%
SILVERARC CAPITAL MANAGEMENT, LLC 204,679$1,631,0000.68%
Atom Investors LP 60,103$479,0000.22%
View complete list of POINT BIOPHARMA GLOBAL INC shareholders